2 August 2012 - Speciality pharmaceutical company Alliance Pharma plc (AIM:APH) announced today the acquisition of three antimalarial brands from Anglo-Swedish pharmaceutical company AstraZeneca plc (LSE:AZN) (STO:AZN) (NYSE:AZN).

Alliance Pharmaceuticals Limited, a wholly owned subsidiary ...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up